Long-term Follow-up for Cystic Fibrosis: A Collaboration with the Cystic Fibrosis Foundation

Similar documents
2012 Medicaid and Partnership Chart

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

2018 HPV Legislative Report Card

ACEP National H1N1 Preparedness Survey Results

Georgina Peacock, MD, MPH

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

Obesity Trends:

National Deaf Center on Postsecondary Outcomes. Data Interpretation Guide for State Reports: FAQ

Autism Activities at CDC: The Public Health Model

CDC activities with Autism Spectrum Disorders

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

The 2004 National Child Count of Children and Youth who are Deaf-Blind

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

Quarterly Hogs and Pigs

Quarterly Hogs and Pigs

April 25, Edward Donnell Ivy, MD, MPH

The Rural Health Workforce. Policy Brief Series. Data and Issues for Policymakers in: Washington Wyoming Alaska Montana Idaho

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

CDC activities Autism Spectrum Disorders

Percent of U.S. State Populations Covered by 100% Smokefree Air Laws April 1, 2018

It's tick time again! Recognizing black-legged (deer ticks) and measuring the spread of Lyme disease

2003 National Immunization Survey Public-Use Data File

Exhibit 1. Change in State Health System Performance by Indicator

Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material

DEPARTMENT OF DEFENSE (AFHSB)

-Type of immunity that is more permanent (WBC can Remember)

DEPARTMENT OF DEFENSE (AFHSB) Seasonal Influenza Surveillance Summary Northern Command -- Week 17 (22 Apr 28 Apr 2018)

DEPARTMENT OF DEFENSE (AFHSB)

Piero Rinaldo, Si Houn Hahn, Dietrich Matern. Biochemical Genetics Laboratory Mayo Clinic College of Medicine Rochester, MN

DEPARTMENT OF DEFENSE (AFHSB)

Plan Details and Rates. Monthly Premium Rate Schedule

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

PETITION FOR DUAL MEMBERSHIP

West Nile virus and other arboviral activity -- United States, 2013 Provisional data reported to ArboNET Tuesday, January 7, 2014

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

DEPARTMENT OF DEFENSE (AFHSB)

Average Number Citations per Recertification Survey

MetLife Foundation Alzheimer's Survey: What America Thinks

MAKING WAVES WITH STATE WATER POLICIES. Washington State Department of Health

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care

DEPARTMENT OF DEFENSE (AFHSB)

The Chiropractic Pediatric CE Credit Program with Emphasis on Autism

Medical Advisory Board. reviews medical issues for licensure regarding individual drivers. medical conditions. not specified. reporting encouraged,

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

DEPARTMENT OF DEFENSE (AFHSB)

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DEPARTMENT OF DEFENSE (AFHSB)

Medical Marijuana Responsible for Traffic Fatalities Alfred Crancer, B.S., M.A.; Phillip Drum, Pharm.D.

Analysis of State Medicaid Agency Performance in Relation to Incentivizing the Provision of H1N1 Immunizations to Eligible Populations

Results from the Commonwealth Fund Scorecard on State Health System Performance. Douglas McCarthy. Senior Research Director The Commonwealth Fund

Forensic Patients in State Hospitals:

DEPARTMENT OF DEFENSE (AFHSB)

If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help

Instant Drug Testing State Law Guide

States with Authority to Require Nonresident Pharmacies to Report to PMP

Health Care Reform: Colorectal Cancer Screening Expansion, Before and After the Affordable Care Act (ACA)

Part I Cox Online Certificate Course

Radiation Therapy Staffing and Workplace Survey 2016

Opioid Deaths Quadruple Since 1999

Geographical Accuracy of Cell Phone Samples and the Effect on Telephone Survey Bias, Variance, and Cost

Perinatal Health in the Rural United States, 2005

Autism and Transition to Adulthood. Lorri Unumb, Esq. Vice President State Government Affairs Autism Speaks

Overview of the States Pesticide Registration Process AAPCO Laboratory Committee

Contents. Introduction. Acknowledgments. 1 Assisted Reproduction and the Diversity of the Modern Family 1. 2 Intrauterine Insemination 31.

HIV in Prisons,

Trends in Lung Cancer Morbidity and Mortality

HIV in Prisons, 2000

Environmental Epidemiology: Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE)

Part I Cox Online Certificate Course

Model Performance Evaluation Program (MPEP) HIV Rapid Testing Survey: Report of Sample Shipment Results, September 2009

The FASD Regional Training Centers: What do they offer and what can they do for you?

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges

Health Care Reform: Colorectal Cancer Screening Disparities, Before and After the Affordable Care Act (ACA)

Pediatric Physicians Workforce Data Book

Methamphetamines: A National and State Crisis. Research Brief. Prepared by

NCDB The National Center on Deaf-Blindness

NCQA did not add new measures to Accreditation 2017 scoring.

Chapter Two Incidence & prevalence

ADVANCE FOR PHYSICAL THERAPY AND REHAB MEDICINE

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

HIV/AIDS in the Rural US Prevalence and Service Availability

West Nile virus and other arboviral activity -- United States, 2016 Provisional data reported to ArboNET Tuesday, October 11, 2016

Medical Marijuana

Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

THE STEPPING UP INITIATIVE

ROAD SAFETY MONITOR. ALCOHOL-IMPAIRED DRIVING IN THE UNITED STATES Results from the 2017 TIRF USA Road Safety Monitor

Supplement to Achieving a State of Healthy Weight

B&T Format. New Measures. Better health care. Better choices. Better health.

Transcription:

Long-term Follow-up for Cystic Fibrosis: A Collaboration with the Cystic Fibrosis Foundation Beth Vogel, MS, CGC NYS Newborn Screening Program Wadsworth Center

Outline Introduction Matching Long-term follow-up

Introduction Long-term follow-up data already entered into the Cystic Fibrosis Foundation Patient Registry Consented Registry Plan: request data from CF Foundation on patients born in NYS

Introduction What long-term follow-up questions are important from a public health standpoint?

Introduction Question 1: Are there individuals with CF in NYS who had a false negative newborn screen and when were they diagnosed? Question 2: What percentage of children in NYS enter and remain in specialty care after receiving a CF diagnosis? Question 3: How many children with cystic fibrosis move into and out of NY?

Introduction Data requested State of birth Patient's date of birth Patient Registry ID All fields in the CF diagnosis category Data year All encounter fields Died in data year

Introduction Data years Patients born from first complete year of CF screening in NYS (2003) to 2010 Submit additional materials to receive data in the future

Question 1 Are there individuals with CF in NYS who had a false negative newborn screen and when were they diagnosed?

Methodology Matching Match NBS data to CFFPR data Goal: Identify false negatives and evaluate matching criteria Match criteria: date of sweat test, sweat chloride value, date of birth, gender and diagnosis

Results Received data for 369 cases from 2003 to 2010 Number of cases in NBS data: 351

Results 68/369 Cases that did not match in NBS data and CFFPR data 81.6% match rate

Results 25 of 68 cases had a likely match Considered likely match if: Matching DOB and gender Different sweat test data or diagnosis Average age of diagnosis 0.29 years (0.044-1.47)

Results No match 43 cases Average age of diagnosis 0.85 years Considered no match if: No newborn in NBS record with a CF diagnosis and matching DOB and gender

No Match N=43 Diagnosis Indicated By NBS N=22 Diagnosis Not Indicated By NBS N=21 Diagnosed Less Than 6 Months N=15 Diagnosed Greater Than 6 Months N=7 Diagnosed Less Than 6 Months N=15 Diagnosed Greater Than 6 Months N=6

No Match N=43 Diagnosis Indicated By NBS N=22 Diagnosis Not Indicated By NBS N=21 False Negatives? Diagnosed Less Than 6 Months N=15 Diagnosed Greater Than 6 Months N=7 Diagnosed Less Than 6 Months N=15 Diagnosed Greater Than 6 Months N=6

Results Diagnosis greater than 6 months and not indicated by newborn screening N=6 Most likely false negatives Average age of diagnosis 3.24 years One case previously known to NBS as false negative

Discussion - Further investigation into these 6 cases Root cause analysis Is there a reasonable corrective action? Consider: impact on false positive rate

Discussion No match: diagnosed <6 months or diagnosis indicated by NBS N=37 Likely represent limitations of matching

Discussion: Limitations of Matching Data quality Data entry errors Case closed as lost to follow-up NBS receiving diagnosis prior to genetic test results available Case closed based on sweat value only Case closed as expired without diagnosis Positive NBS in another state Not screened

Discussion Source of Bias False negatives that have not been diagnosed yet or have not been entered into the CFFPR

Conclusions Unique identifier would help with analysis and interpretation Sweat test not always good for matching because it is sometimes repeated after diagnosis form sent to NBS

Questions Question 2: What percentage of children in NYS enter and remain in specialty care after receiving a CF diagnosis

Methods - Long-term Follow-up Data from CFFPR: Year and number of encounters for each patient Encounter after the diagnosis date? Encounter in 2010? Year of life the last encounter occurred?

Results - Long-term Follow-up Confirmed visit at CF Center after diagnosis 357 out of 368 (97%)

Results - Long-term Follow-up 63 out of 366 (17%) did not have a visit in the CFFPR in 2010 possibly lost to follow-up, discharged from care or not updated in registry Deceased patients were excluded (N=3)

Long-term Follow-up Results Percent Patients with an Encounter in CFFPR in 2010 for Each Year of Birth 100 95 90 85 80 75 70 65 60 55 50 2010 2009 2008 2007 2006 2005 2004 2003 Percent

Long-term Follow-up - Results Year of Life Number of Patients with Their Last Encounter in the Year <1 5 7.9 1 8 12.7 2 12 19.05 3 9 14.29 4 10 15.87 5 10 15.87 6 9 14.29 Percent of Total (N=63)

Long-term Follow-up - Results Percent of Patients Whose Last Encounter in the CFFPR Occurred During Each Year of Life (N=63) 25 20 15 10 Percent 5 0 <1 1 2 3 4 5 6

Discussion Long-term Follow-up At least 90% of patients born in 2007 and later had a visit in the CFFPR in 2010 More studies needed to determine why ~17% of patients did not have a visit in 2010

Question Question 3: How many children with cystic fibrosis move into and out of NY?

Results Long-term Follow-up Patients that moved out of state 15 patients moved out of state 15/369 4.1% Oregon, Ohio, Texas, South Carolina, Florida, Michigan, Connecticut (3), Kentucky, New Jersey, New Hampshire, North Carolina, Utah, Vermont

Results Long-term Follow-up Live in Another State 15/369 4.1% New Jersey (6), Colorado, North Carolina (3), Pennsylvania, Virginia, Connecticut, Maryland, Florida

Results Long-term Follow-up 6 moved into NY from another state All born in NY Vermont (2), New Hampshire (2), Connecticut, Missouri 18 with an unknown state of residence for initial entry in CFFPR All born in NY

Conclusions Data would not be available for approximately 8% of patients if it was not from the CFFPR Could be as low as 4.6% if patients in border states are followed at NY Center

Acknowledgements Funding Support through HRSA 09-242 Cystic Fibrosis Foundation

Thank you! Questions?